Literature DB >> 9622018

Regional distribution of urocortin-like immunoreactivity and expression of urocortin mRNA in the human brain.

K Takahashi1, K Totsune, M Sone, O Murakami, F Satoh, Z Arihara, H Sasano, K Iino, T Mouri.   

Abstract

Regional distribution of urocortin-like immunoreactivity (UCN-LI) in the human brain was studied by radioimmunoassay and was compared with that of corticotropin-releasing hormone (CRH). In addition, the expression of UCN mRNA was examined by reverse transcriptase-polymerase chain reaction (RT-PCR) method. UCN-LI was detected in every region of brain examined, including hypothalamus, pons, cerebral cortex, and cerebellum. The concentrations of UCN-LI in the human brain were approximately 3 pmol/g wet weight in any brain region, and no marked regional difference was noted. On the other hand, the highest concentrations of CRH-LI were found in the frontal cortex, temporal cortex, and hypothalamus and the lowest in the pons. Reverse phase high-performance liquid chromatography of the UCN-LI in the human brain extract showed two immunoreactive peaks; one peak eluting earlier and one in the position of synthetic human UCN. RT-PCR showed that UCN mRNA was expressed in every region of brain examined. These findings indicated that UCN and UCN mRNA were widely expressed in the human brain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9622018     DOI: 10.1016/s0196-9781(98)00012-6

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  13 in total

1.  Localization of corticoliberin receptors in the rat brain.

Authors:  E A Rybnikova; M Pelto-Huikko; V V Rakitskaya; V G Shalyapina
Journal:  Neurosci Behav Physiol       Date:  2003-05

Review 2.  The corticotropin releasing factor system in cancer: expression and pathophysiological implications.

Authors:  Athina Kaprara; Kalliopi Pazaitou-Panayiotou; Alexandros Kortsaris; Ekaterini Chatzaki
Journal:  Cell Mol Life Sci       Date:  2010-02-09       Impact factor: 9.261

Review 3.  Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.

Authors:  Richard L Hauger; Victoria Risbrough; Olaf Brauns; Frank M Dautzenberg
Journal:  CNS Neurol Disord Drug Targets       Date:  2006-08       Impact factor: 4.388

4.  Urocortin hyperpolarizes stomach smooth muscle via activation of Ca2+-sensitive K+ currents.

Authors:  P S Petkova-Kirova; H S Gagov; D B Duridanova
Journal:  J Muscle Res Cell Motil       Date:  2000       Impact factor: 2.698

5.  Urocortin 1 modulates immunosignaling in a rat model of colitis via corticotropin-releasing factor receptor 2.

Authors:  Jen Chang; Melanie R Adams; Matthew S Clifton; Min Liao; Julia H Brooks; Burcu Hasdemir; Aditi Bhargava
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-17       Impact factor: 4.052

Review 6.  Role of urocortin in pregnancy: An update and future perspectives.

Authors:  Salvatore Giovanni Vitale; Antonio Simone Laganà; Agnese Maria Chiara Rapisarda; Maria Giovanna Scarale; Francesco Corrado; Pietro Cignini; Salvatore Butticè; Diego Rossetti
Journal:  World J Clin Cases       Date:  2016-07-16       Impact factor: 1.337

Review 7.  Urocortin and the brain.

Authors:  Weihong Pan; Abba J Kastin
Journal:  Prog Neurobiol       Date:  2007-11-07       Impact factor: 11.685

8.  Urocortin 2 expression in the rat gastrointestinal tract under basal conditions and in chemical colitis.

Authors:  Jen Chang; Julia J Hoy; Prema S Idumalla; Matthew S Clifton; Norman C Pecoraro; Aditi Bhargava
Journal:  Peptides       Date:  2007-05-21       Impact factor: 3.750

Review 9.  Chronic and acute effects of stress on energy balance: are there appropriate animal models?

Authors:  Ruth B S Harris
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-12-17       Impact factor: 3.619

10.  The cytokine ciliary neurotrophic factor (CNTF) activates hypothalamic urocortin-expressing neurons both in vitro and in vivo.

Authors:  Matthew J Purser; Prasad S Dalvi; Zi C Wang; Denise D Belsham
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.